Penile Girth Enhancement using Amniotic Membrane in a Rabbit Model: A stereological study

Objectives: This study aimed to evaluate the efficacy of Penile Girth Enhancement (PGE) using Amniotic Membrane (AM) as a graft in a rabbit model. Additionally, stereological studies were used to obtain quantitative histological data regarding the structure of the penis. Methods: In this study, 20 adult male rabbits of similar age and weight were allocated to two sham and surgery+AM groups. Both groups underwent surgery by longitudinal Ishape midline incision of the tunica albuginea on the dorsal surface of the penis. The surgery +AM group underwent PGE by AM graft. The penile length and mid circumference were measured using a Vernier caliper before and two months after the surgery. Stereological studies were used to obtain quantitative histological data regarding the structure of the penis. Results: The mean total volume and diameter of the penis increased in the surgery +AM group (p<0.03 and p<0.04, respectively). The stereological evaluation showed a significant increase in the mean volumes of the tunica albuginea and corpora cavernosa in the surgery +AM group compared to the sham group (p<0.01, p< 0.03). Additionally, the mean volume density of the collagen bundles, muscle fibers, and cavernous sinuses and the total number of fibroblasts and smooth muscle cells increased in the surgery +AM group compared to the sham group (p<0.01, p<0.01, p<0.03, p<0.01, and p<0.05, respectively). No infections, bleedings, or other complications were seen. Conclusions: AM is a method that has appeared promising for material use in penile enhancement. Thus, it may be used for PGE in the future. Keywords: Amniotic Membrane; Histopathology; Animal; Penile Girth Enhancement

Advancing nanoelectronic device modeling through peta-scale computing and deployment on nanoHUB

Recent improvements to existing HPC codes NEMO 3-D and OMEN, combined with access to peta-scale computing resources, have enabled realistic device engineering simulations that were previously infeasible. NEMO 3-D can now simulate 1 billion atom systems, and, using 3D spatial decomposition, scale to 32768 cores. Simulation time for the band structure of an experimental P doped Si quantum computing device fell from 40 minutes to I minute. OMEN can perform fully quantum mechanical transport calculations for real-word UTB FETs on 147,456 cores in roughly 5 minutes. Both of these tools power simulation engines on the nanoHUB, giving the community access to previously unavailable research capabilities

Eigenvalue solvers for atomistic simulations of electronic structures with NEMO-3D

The atomistic simulations of electronic structures, using a tight binding model with millions of atoms, require solution of very large sparse Hermitian eigenvalue problems. To obtain the eigenpairs of interest in the interior of the spectrum, we must take advantage of the most efficient parallel numerical algorithms. Several methods have been developed and implemented in Nanoelectronic Modeling software package NEMO-3D, including (P)ARPACK, (Block) Lanczos and Tracemin. In this paper, the performance and tradeoffs of these algorithms for realistic models are discussed. The effectiveness of code optimization techniques such as SSE2 vectorization is also presented

Application benchmark results for Big Red, an IBM e1350 BladeCenter Cluster

The purpose of this report is to present the results of benchmark tests with Big Red, an IBM e1350 BladeCenter Cluster. This report is particularly focused on providing details of system architecture and test run results in detail to allow for analysis in other reports and comparison with other systems, rather than presenting such analysis here

Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis

BACKGROUND: Rates of antimicrobial resistance (AMR) are rising globally and there is concern that increased migration is contributing to the burden of antibiotic resistance in Europe. However, the effect of migration on the burden of AMR in Europe has not yet been comprehensively examined. Therefore, we did a systematic review and meta-analysis to identify and synthesise data for AMR carriage or infection in migrants to Europe to examine differences in patterns of AMR across migrant groups and in different settings. METHODS: For this systematic review and meta-analysis, we searched MEDLINE, Embase, PubMed, and Scopus with no language restrictions from Jan 1, 2000, to Jan 18, 2017, for primary data from observational studies reporting antibacterial resistance in common bacterial pathogens among migrants to 21 European Union-15 and European Economic Area countries. To be eligible for inclusion, studies had to report data on carriage or infection with laboratory-confirmed antibiotic-resistant organisms in migrant populations. We extracted data from eligible studies and assessed quality using piloted, standardised forms. We did not examine drug resistance in tuberculosis and excluded articles solely reporting on this parameter. We also excluded articles in which migrant status was determined by ethnicity, country of birth of participants' parents, or was not defined, and articles in which data were not disaggregated by migrant status. Outcomes were carriage of or infection with antibiotic-resistant organisms. We used random-effects models to calculate the pooled prevalence of each outcome. The study protocol is registered with PROSPERO, number CRD42016043681. FINDINGS: We identified 2274 articles, of which 23 observational studies reporting on antibiotic resistance in 2319 migrants were included. The pooled prevalence of any AMR carriage or AMR infection in migrants was 25·4% (95% CI 19·1-31·8; I2 =98%), including meticillin-resistant Staphylococcus aureus (7·8%, 4·8-10·7; I2 =92%) and antibiotic-resistant Gram-negative bacteria (27·2%, 17·6-36·8; I2 =94%). The pooled prevalence of any AMR carriage or infection was higher in refugees and asylum seekers (33·0%, 18·3-47·6; I2 =98%) than in other migrant groups (6·6%, 1·8-11·3; I2 =92%). The pooled prevalence of antibiotic-resistant organisms was slightly higher in high-migrant community settings (33·1%, 11·1-55·1; I2 =96%) than in migrants in hospitals (24·3%, 16·1-32·6; I2 =98%). We did not find evidence of high rates of transmission of AMR from migrant to host populations. INTERPRETATION: Migrants are exposed to conditions favouring the emergence of drug resistance during transit and in host countries in Europe. Increased antibiotic resistance among refugees and asylum seekers and in high-migrant community settings (such as refugee camps and detention facilities) highlights the need for improved living conditions, access to health care, and initiatives to facilitate detection of and appropriate high-quality treatment for antibiotic-resistant infections during transit and in host countries. Protocols for the prevention and control of infection and for antibiotic surveillance need to be integrated in all aspects of health care, which should be accessible for all migrant groups, and should target determinants of AMR before, during, and after migration. FUNDING: UK National Institute for Health Research Imperial Biomedical Research Centre, Imperial College Healthcare Charity, the Wellcome Trust, and UK National Institute for Health Research Health Protection Research Unit in Healthcare-associated Infections and Antimictobial Resistance at Imperial College London

Surgical site infection after gastrointestinal surgery in high-income, middle-income, and low-income countries: a prospective, international, multicentre cohort study

Background: Surgical site infection (SSI) is one of the most common infections associated with health care, but its importance as a global health priority is not fully understood. We quantified the burden of SSI after gastrointestinal surgery in countries in all parts of the world. Methods: This international, prospective, multicentre cohort study included consecutive patients undergoing elective or emergency gastrointestinal resection within 2-week time periods at any health-care facility in any country. Countries with participating centres were stratified into high-income, middle-income, and low-income groups according to the UN's Human Development Index (HDI). Data variables from the GlobalSurg 1 study and other studies that have been found to affect the likelihood of SSI were entered into risk adjustment models. The primary outcome measure was the 30-day SSI incidence (defined by US Centers for Disease Control and Prevention criteria for superficial and deep incisional SSI). Relationships with explanatory variables were examined using Bayesian multilevel logistic regression models. This trial is registered with ClinicalTrials.gov, number NCT02662231. Findings: Between Jan 4, 2016, and July 31, 2016, 13 265 records were submitted for analysis. 12 539 patients from 343 hospitals in 66 countries were included. 7339 (58·5%) patient were from high-HDI countries (193 hospitals in 30 countries), 3918 (31·2%) patients were from middle-HDI countries (82 hospitals in 18 countries), and 1282 (10·2%) patients were from low-HDI countries (68 hospitals in 18 countries). In total, 1538 (12·3%) patients had SSI within 30 days of surgery. The incidence of SSI varied between countries with high (691 [9·4%] of 7339 patients), middle (549 [14·0%] of 3918 patients), and low (298 [23·2%] of 1282) HDI (p < 0·001). The highest SSI incidence in each HDI group was after dirty surgery (102 [17·8%] of 574 patients in high-HDI countries; 74 [31·4%] of 236 patients in middle-HDI countries; 72 [39·8%] of 181 patients in low-HDI countries). Following risk factor adjustment, patients in low-HDI countries were at greatest risk of SSI (adjusted odds ratio 1·60, 95% credible interval 1·05–2·37; p=0·030). 132 (21·6%) of 610 patients with an SSI and a microbiology culture result had an infection that was resistant to the prophylactic antibiotic used. Resistant infections were detected in 49 (16·6%) of 295 patients in high-HDI countries, in 37 (19·8%) of 187 patients in middle-HDI countries, and in 46 (35·9%) of 128 patients in low-HDI countries (p < 0·001). Interpretation: Countries with a low HDI carry a disproportionately greater burden of SSI than countries with a middle or high HDI and might have higher rates of antibiotic resistance. In view of WHO recommendations on SSI prevention that highlight the absence of high-quality interventional research, urgent, pragmatic, randomised trials based in LMICs are needed to assess measures aiming to reduce this preventable complication

A Short Note Comparing Multigrid and Domain Decomposition for Protein Modeling Equations

We consider multigrid and domain decomposition methods for the numerical solution of electrostatics problems arising in biophysics. We compare multigrid methods designed for discontinuous coefficients with domain decomposition methods, including comparisons of standard multigrid methods, algebraic multigrid methods, additive and multiplicative Schwarz domain decomposition methods, and acceleration of multigrid and domain decomposition methods with conjugate gradient methods. As a test problem, we consider a linearization of the Poisson-Boltzmann equation, which describes the electrostatic potential of a large complex biomolecule lying in an ionic solvent

A Short Note Comparing Multigrid and Domain Decomposition for Protein Modeling Equations

We consider multigrid and domain decomposition methods for the numerical solution of electrostatics problems arising in biophysics. We compare multigrid methods designed for discontinuous coe#cients with domain decomposition methods, including comparisons of standard multigrid methods, algebraic multigrid methods, additive and multiplicative Schwarz domain decomposition methods, and acceleration of multigrid and domain decomposition methods with conjugate gradient methods. As a test problem, we consider a linearization of the Poisson-Boltzmann equation, which describes the electrostatic potential of a large complex biomolecule lying in an ionic solvent